Invite only

MIT Startup Exchange December Demo Day

December 8, 2021
Virtual Event
MIT Startup Exchange December Demo Day

Location

Virtual Event

Overview

MIT Startup Exchange is convening our third MIT Startup Exchange Demo Day on Wednesday, December 8 (11 AM – 12:15 PM ET). The event will feature eight industry-ready startups, with each presenting for 4 mins followed by 2 mins of Q&A. Breakout rooms will follow at the end of the event.

This event is for ILP members. You can confirm your company's ILP membership here: https://ilp.mit.edu/search/members.

  • Overview

    MIT Startup Exchange is convening our third MIT Startup Exchange Demo Day on Wednesday, December 8 (11 AM – 12:15 PM ET). The event will feature eight industry-ready startups, with each presenting for 4 mins followed by 2 mins of Q&A. Breakout rooms will follow at the end of the event.

    This event is for ILP members. You can confirm your company's ILP membership here: https://ilp.mit.edu/search/members.

Register

Agenda

11:00 AM
Welcome and Introduction
Program Director, MIT Startup Exchange
Marcus Dahllöf
Marcus Dahllöf
Program Director

Marcus leads the MIT Startup Exchange, which facilitates connections between MIT-connected startups and corporate members of the MIT Industrial Liaison Program (ILP). Marcus manages networking events, workshops, the STEX25 accelerator, opportunity postings, and helps define the strategic direction of MIT Startup Exchange. He is a two-time tech entrepreneur (one exit in cybersecurity), and has previously held roles in finance, software engineering, corporate strategy, and business development at emerging tech companies and Fortune 100 corporations in the U.S., Latin America, and Europe. Marcus was a member of the Swedish national rowing team and he is a mentor at the MIT Venture Mentoring Service.

11:05 AM
Lightning Talks and Q&A
CellChorus: Dynamic single-cell analysis at scale
Daniel Meyer
CEO, CellChorus
Daniel Meyer
CEO

Daniel Meyer is the CEO of CellChorus. He is the former Chief Operating Officer and was a board member of Genospace, which was funded by Thomson Reuters/Clarivate and acquired by HCA Healthcare (NYSE:HCA), the largest private hospital company in the United States and one of the largest oncology clinical care and clinical trial organizations in the United States, having led more than 450 first-in-man clinical trials and having been a clinical trial leader in the majority of approved cancer therapies over the last ten years.

Mr. Meyer was also a member of the early stage healthcare and life sciences investment teams at Arboretum Ventures and PJC.vc, where he focused on investments in life sciences, medical devices, health care information technology, and health care services. Mr. Meyer holds an MBA from the Tuck School of Business at Dartmouth and a BA from Middlebury College.

Kinovi: Drug-target kinetic binding data for AI-assisted drug discovery
Joseph Azzarelli
Founder & CEO, Kinovi
Joseph Azzarelli
Founder & CEO

Kinovi, founded by Joseph Azzarelli in 2021, is devoted to accelerating small molecule drug discovery with a novel high-throughput drug-protein binding kinetics platform. Dr. Azzarelli has been a deep tech entrepreneur with a focus on commercializing innovative diagnostic and therapeutic technologies since completing his Ph.D. at MIT (Chemistry '16).

Phuc Labs: AI-powered fluidic particle sorting
Phuc Vinh Truong
CEO & Co-founder, Phuc Labs
Phuc Vinh Truong
CEO & Co-founder

Phuc Vinh Truong is CEO and Co-founder of Phuc Labs, an AI-powered fluidic particle sorting startup. Phuc is a seasoned entrepreneur with over 20 years of experience, and a computer science expert. He’s been a Co-founder of 4+ VC funded companies. Phuc has a BS degree in Economics from Harvard University.

Xibus Systems: Bioengineered pathogen detection solutions
Peter Antoinette
Peter Antoinette
CEO

Peter has thirty years of experience in life science and industrial markets. He was lead founder of Nanocomp Technologies, Inc. (Merrimack, NH) leading it to international leadership in carbon nano-materials and acquisition by Huntsman Chemicals (Woodlands, TX).  Prior he was CEO of CRI Inc. (Woburn, MA) commercializing liquid crystal-based products for drug discovery and telecom. Previously, with Millipore Corporation, he was a division vice-president commercialized products for molecular biology research, industrial bio-pharma manufacturing. He holds nine patents in bioresearch and nanotech materials. He has served as a Director on the New Hampshire High Technology Council; co-chaired the Industrial Advisory Board for the Center for High-Rate Nanomanufacturing (Northeastern); member of United States Senator Jeanne Shaheen’s Small Business Advisory Council; and the Nanotechnology Advisory Panel for President Obama’s Council of Advisers for Science & Technology. 

Skylla Technologies: Human-aware robotics solutions
Kota Weaver
Co-founder & CTO, Skylla Technologies
Kota Weaver
Co-founder & CTO

Kota Weaver is a co-founder and CTO of Skylla Technologies, located in Lexington, Massachusetts, and a spin-off from Prof. Harry Asada’s lab at MIT. Skylla is transforming the manufacturing industry with its Jetstream Controller, a robot intelligence platform that features human-aware navigation and exceptional endpoint positioning accuracy. Skylla can help customers quickly and cost effectively deploy mobile manipulators and other vehicular robots for a wide range of applications in manufacturing, construction, and public service. Kota has prior experience at Neurala and Boston Incubation Center, working on various AI/ML, computer vision and robotics projects. He has a BS degree in Computer Science from Rensselaer Polytechnic Institute.

 

Themis AI: The future of fair Artificial Intelligence
Elaheh Ahmadi
Co-founder & CEO, Themis AI
Elaheh Ahmadi
Co-founder & CEO

Elaheh Ahmadi is a Co-founder and CEO of Themis AI Inc. She received her Bs and MEng in Electrical Engineering and Computer Science at MIT. Ahmadi committed her Master’s thesis to mitigating and identifying bias in clinical trials outcome prediction. Along with her colleagues at Daniela Rus's lab at CSAIL they developed algorithms resulting in an estimated net-profit of more than $700M per trial. Her passion in fair society and developing fair technology and the successful research results motivated her and her co-founders to start Themis AI with the mission to provide debiasing services to any company that utilizes AI in their pipeline.

 

Akkio: Modern business runs on no-code AI
Craig Wisneski
Co-founder, Akkio
Craig Wisneski
Co-founder

Craig Wisneski is a Co-Founder of Akkio, the no-code AI company, that makes artificial intelligence easy enough for any company to become an AI-powered business. He previously led Product at digital manufacturer Markforged ($MKFG) and helped speaker maker Sonos ($SONO) grow from a startup to over $1B in revenue in various product leadership roles. He has a SM from the MIT Media Lab ('99) and SB from MIT ('97).

 

12:00 PM
Breakout Rooms
12:15 PM
Adjournment
  • Agenda
    11:00 AM
    Welcome and Introduction
    Program Director, MIT Startup Exchange
    Marcus Dahllöf
    Marcus Dahllöf
    Program Director

    Marcus leads the MIT Startup Exchange, which facilitates connections between MIT-connected startups and corporate members of the MIT Industrial Liaison Program (ILP). Marcus manages networking events, workshops, the STEX25 accelerator, opportunity postings, and helps define the strategic direction of MIT Startup Exchange. He is a two-time tech entrepreneur (one exit in cybersecurity), and has previously held roles in finance, software engineering, corporate strategy, and business development at emerging tech companies and Fortune 100 corporations in the U.S., Latin America, and Europe. Marcus was a member of the Swedish national rowing team and he is a mentor at the MIT Venture Mentoring Service.

    11:05 AM
    Lightning Talks and Q&A
    CellChorus: Dynamic single-cell analysis at scale
    Daniel Meyer
    CEO, CellChorus
    Daniel Meyer
    CEO

    Daniel Meyer is the CEO of CellChorus. He is the former Chief Operating Officer and was a board member of Genospace, which was funded by Thomson Reuters/Clarivate and acquired by HCA Healthcare (NYSE:HCA), the largest private hospital company in the United States and one of the largest oncology clinical care and clinical trial organizations in the United States, having led more than 450 first-in-man clinical trials and having been a clinical trial leader in the majority of approved cancer therapies over the last ten years.

    Mr. Meyer was also a member of the early stage healthcare and life sciences investment teams at Arboretum Ventures and PJC.vc, where he focused on investments in life sciences, medical devices, health care information technology, and health care services. Mr. Meyer holds an MBA from the Tuck School of Business at Dartmouth and a BA from Middlebury College.

    Kinovi: Drug-target kinetic binding data for AI-assisted drug discovery
    Joseph Azzarelli
    Founder & CEO, Kinovi
    Joseph Azzarelli
    Founder & CEO

    Kinovi, founded by Joseph Azzarelli in 2021, is devoted to accelerating small molecule drug discovery with a novel high-throughput drug-protein binding kinetics platform. Dr. Azzarelli has been a deep tech entrepreneur with a focus on commercializing innovative diagnostic and therapeutic technologies since completing his Ph.D. at MIT (Chemistry '16).

    Phuc Labs: AI-powered fluidic particle sorting
    Phuc Vinh Truong
    CEO & Co-founder, Phuc Labs
    Phuc Vinh Truong
    CEO & Co-founder

    Phuc Vinh Truong is CEO and Co-founder of Phuc Labs, an AI-powered fluidic particle sorting startup. Phuc is a seasoned entrepreneur with over 20 years of experience, and a computer science expert. He’s been a Co-founder of 4+ VC funded companies. Phuc has a BS degree in Economics from Harvard University.

    Xibus Systems: Bioengineered pathogen detection solutions
    Peter Antoinette
    Peter Antoinette
    CEO

    Peter has thirty years of experience in life science and industrial markets. He was lead founder of Nanocomp Technologies, Inc. (Merrimack, NH) leading it to international leadership in carbon nano-materials and acquisition by Huntsman Chemicals (Woodlands, TX).  Prior he was CEO of CRI Inc. (Woburn, MA) commercializing liquid crystal-based products for drug discovery and telecom. Previously, with Millipore Corporation, he was a division vice-president commercialized products for molecular biology research, industrial bio-pharma manufacturing. He holds nine patents in bioresearch and nanotech materials. He has served as a Director on the New Hampshire High Technology Council; co-chaired the Industrial Advisory Board for the Center for High-Rate Nanomanufacturing (Northeastern); member of United States Senator Jeanne Shaheen’s Small Business Advisory Council; and the Nanotechnology Advisory Panel for President Obama’s Council of Advisers for Science & Technology. 

    Skylla Technologies: Human-aware robotics solutions
    Kota Weaver
    Co-founder & CTO, Skylla Technologies
    Kota Weaver
    Co-founder & CTO

    Kota Weaver is a co-founder and CTO of Skylla Technologies, located in Lexington, Massachusetts, and a spin-off from Prof. Harry Asada’s lab at MIT. Skylla is transforming the manufacturing industry with its Jetstream Controller, a robot intelligence platform that features human-aware navigation and exceptional endpoint positioning accuracy. Skylla can help customers quickly and cost effectively deploy mobile manipulators and other vehicular robots for a wide range of applications in manufacturing, construction, and public service. Kota has prior experience at Neurala and Boston Incubation Center, working on various AI/ML, computer vision and robotics projects. He has a BS degree in Computer Science from Rensselaer Polytechnic Institute.

     

    Themis AI: The future of fair Artificial Intelligence
    Elaheh Ahmadi
    Co-founder & CEO, Themis AI
    Elaheh Ahmadi
    Co-founder & CEO

    Elaheh Ahmadi is a Co-founder and CEO of Themis AI Inc. She received her Bs and MEng in Electrical Engineering and Computer Science at MIT. Ahmadi committed her Master’s thesis to mitigating and identifying bias in clinical trials outcome prediction. Along with her colleagues at Daniela Rus's lab at CSAIL they developed algorithms resulting in an estimated net-profit of more than $700M per trial. Her passion in fair society and developing fair technology and the successful research results motivated her and her co-founders to start Themis AI with the mission to provide debiasing services to any company that utilizes AI in their pipeline.

     

    Akkio: Modern business runs on no-code AI
    Craig Wisneski
    Co-founder, Akkio
    Craig Wisneski
    Co-founder

    Craig Wisneski is a Co-Founder of Akkio, the no-code AI company, that makes artificial intelligence easy enough for any company to become an AI-powered business. He previously led Product at digital manufacturer Markforged ($MKFG) and helped speaker maker Sonos ($SONO) grow from a startup to over $1B in revenue in various product leadership roles. He has a SM from the MIT Media Lab ('99) and SB from MIT ('97).

     

    12:00 PM
    Breakout Rooms
    12:15 PM
    Adjournment

Disclaimer:  MIT Startup Exchange can make introductions that ideally provide open ended discussions in order to share mutual interests and potentially create common ground that incite the parties to collaborate. MIT Startup Exchange introductions may eventually lead to mutual partnerships, but that is not in any way guaranteed by MIT, MIT Corporate Relations, MIT Industrial Liaison Program (ILP) or MIT Startup Exchange, which takes no responsibility for these outcomes and no formal part in such discussions following our introduction. MIT Startup Exchange and its activities and events are not for purposes of soliciting investment or offering securities.